Tandem Diabetes Care Inc.

16.86
-0.40 (-2.32%)
At close: Apr 17, 2025, 3:59 PM
17.12
1.55%
After-hours: Apr 17, 2025, 07:55 PM EDT

Tandem Diabetes Care Statistics

Share Statistics

Tandem Diabetes Care has 66.56M shares outstanding. The number of shares has increased by 2.92% in one year.

Shares Outstanding 66.56M
Shares Change (YoY) 2.92%
Shares Change (QoQ) 1.21%
Owned by Institutions (%) 99.99%
Shares Floating 66.01M
Failed to Deliver (FTD) Shares 100
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 7.27M, so 10.94% of the outstanding shares have been sold short.

Short Interest 7.27M
Short % of Shares Out 10.94%
Short % of Float 16.82%
Short Ratio (days to cover) 6.52

Valuation Ratios

The PE ratio is -24.55 and the forward PE ratio is -25.54. Tandem Diabetes Care's PEG ratio is 0.43.

PE Ratio -24.55
Forward PE -25.54
PS Ratio 2.51
Forward PS 0.8
PB Ratio 8.96
P/FCF Ratio 472.08
PEG Ratio 0.43
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tandem Diabetes Care.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.93, with a Debt / Equity ratio of 1.8.

Current Ratio 2.93
Quick Ratio 2.33
Debt / Equity 1.8
Debt / EBITDA -4.78
Debt / FCF 94.83
Interest Coverage -17.99

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $354.79K
Profits Per Employee $-36.24K
Employee Count 2,650
Asset Turnover 0.97
Inventory Turnover 3.01

Taxes

Income Tax 4.16M
Effective Tax Rate -4.52%

Stock Price Statistics

The stock price has increased by -45.49% in the last 52 weeks. The beta is 1.53, so Tandem Diabetes Care's price volatility has been higher than the market average.

Beta 1.53
52-Week Price Change -45.49%
50-Day Moving Average 22.92
200-Day Moving Average 34.1
Relative Strength Index (RSI) 33.57
Average Volume (20 Days) 1.64M

Income Statement

In the last 12 months, Tandem Diabetes Care had revenue of 940.2M and earned -96.03M in profits. Earnings per share was -1.47.

Revenue 940.2M
Gross Profit 489.57M
Operating Income -99.13M
Net Income -96.03M
EBITDA -99.13M
EBIT -99.28M
Earnings Per Share (EPS) -1.47
Full Income Statement

Balance Sheet

The company has 69.23M in cash and 473.56M in debt, giving a net cash position of -404.33M.

Cash & Cash Equivalents 69.23M
Total Debt 473.56M
Net Cash -404.33M
Retained Earnings -1.05B
Total Assets 967.66M
Working Capital 477.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 24.23M and capital expenditures -19.23M, giving a free cash flow of 4.99M.

Operating Cash Flow 24.23M
Capital Expenditures -19.23M
Free Cash Flow 4.99M
FCF Per Share 0.08
Full Cash Flow Statement

Margins

Gross margin is 52.07%, with operating and profit margins of -10.54% and -10.21%.

Gross Margin 52.07%
Operating Margin -10.54%
Pretax Margin -9.77%
Profit Margin -10.21%
EBITDA Margin -10.54%
EBIT Margin -10.54%
FCF Margin 0.53%

Dividends & Yields

TNDM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for TNDM is $49, which is 190.6% higher than the current price. The consensus rating is "Buy".

Price Target $49
Price Target Difference 190.6%
Analyst Consensus Buy
Analyst Count 16
Stock Forecasts

Stock Splits

The last stock split was on Oct 10, 2017. It was a backward split with a ratio of 1:10.

Last Split Date Oct 10, 2017
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score 0.83
Piotroski F-Score 4